According to Elanco's latest financial reports the company has $0.35 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.35 B | 2.03% |
2022-12-31 | $0.34 B | -45.92% |
2021-12-31 | $0.63 B | 28.89% |
2020-12-31 | $0.49 B | 48.2% |
2019-12-31 | $0.33 B | -29.65% |
2018-12-31 | $0.47 B | 46.82% |
2017-12-31 | $0.32 B | 24.96% |
2016-12-31 | $0.25 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -72.76% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -92.83% | ๐บ๐ธ USA |